QuiaPEG Pharmaceuticals Holding AB (publ) (QUIA.ST)

SEK 0.0

(4.26%)

Long Term Debt Summary of QuiaPEG Pharmaceuticals Holding AB (publ)

  • QuiaPEG Pharmaceuticals Holding AB (publ)'s latest annual long term debt in 2023 was - SEK , down -100.0% from previous year.
  • QuiaPEG Pharmaceuticals Holding AB (publ)'s latest quarterly long term debt in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • QuiaPEG Pharmaceuticals Holding AB (publ) reported annual long term debt of 15.2 Million SEK in 2022, down -10.66% from previous year.
  • QuiaPEG Pharmaceuticals Holding AB (publ) reported annual long term debt of 17.02 Million SEK in 2021, up 1382.67% from previous year.
  • QuiaPEG Pharmaceuticals Holding AB (publ) reported quarterly long term debt of - SEK for 2024 Q1, down 0.0% from previous quarter.
  • QuiaPEG Pharmaceuticals Holding AB (publ) reported quarterly long term debt of 11.67 Million SEK for 2023 Q1, down -23.23% from previous quarter.

Annual Long Term Debt Chart of QuiaPEG Pharmaceuticals Holding AB (publ) (2023 - 2008)

Historical Annual Long Term Debt of QuiaPEG Pharmaceuticals Holding AB (publ) (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 - SEK -100.0%
2022 15.2 Million SEK -10.66%
2021 17.02 Million SEK 1382.67%
2020 1.14 Million SEK -91.52%
2019 13.53 Million SEK 445.63%
2018 2.48 Million SEK -0.76%
2017 2.5 Million SEK 0.0%
2016 - SEK -100.0%
2015 218 Thousand SEK -65.62%
2014 634 Thousand SEK 13.21%
2013 560 Thousand SEK -24.02%
2012 737 Thousand SEK -22.34%
2011 949 Thousand SEK -12.29%
2010 1.08 Million SEK -25.17%
2009 1.44 Million SEK -14.94%
2008 1.7 Million SEK 0.0%

Peer Long Term Debt Comparison of QuiaPEG Pharmaceuticals Holding AB (publ)

Name Long Term Debt Long Term Debt Difference
NextCell Pharma AB - SEK NaN%
Biovica International AB (publ) 4.29 Million SEK 100.0%
Abliva AB (publ) 424 Thousand SEK 100.0%
Active Biotech AB (publ) 3 Million SEK 100.0%
Aptahem AB (publ) - SEK NaN%
Alligator Bioscience AB (publ) 7.51 Million SEK 100.0%
BioInvent International AB (publ) 14.53 Million SEK 100.0%
BioArctic AB (publ) 2.15 Million SEK 100.0%
Bio-Works Technologies AB (publ) - SEK NaN%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 100.0%
Cantargia AB (publ) - SEK NaN%
Scandinavian ChemoTech AB (publ) - SEK NaN%
CombiGene AB (publ) - SEK NaN%
Egetis Therapeutics AB (publ) 103.4 Million SEK 100.0%
Fluicell AB (publ) - SEK NaN%
Genovis AB (publ.) 74.8 Million SEK 100.0%
Hansa Biopharma AB (publ) 844.9 Million SEK 100.0%
Mendus AB (publ) 850 Thousand SEK 100.0%
Karolinska Development AB (publ) - SEK NaN%
LIDDS AB (publ) - SEK NaN%
Saniona AB (publ) 65.23 Million SEK 100.0%
Spago Nanomedical AB (publ) - SEK NaN%
Sprint Bioscience AB (publ) - SEK NaN%
Xintela AB (publ) - SEK NaN%
Amniotics AB (publ) - SEK NaN%
Corline Biomedical AB - SEK NaN%
Elicera Therapeutics AB (publ) - SEK NaN%
Infant Bacterial Therapeutics AB (publ) - SEK NaN%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 100.0%
Intervacc AB (publ) 142 Thousand SEK 100.0%
Kancera AB (publ) - SEK NaN%
Lipum AB (publ) 1.76 Million SEK 100.0%
Lipigon Pharmaceuticals AB (publ) - SEK NaN%
Nanologica AB (publ) 136 Thousand SEK 100.0%
Vicore Pharma Holding AB (publ) - SEK NaN%
Xbrane Biopharma AB (publ) 112.89 Million SEK 100.0%
AcouSort AB (publ) - SEK NaN%
Diamyd Medical AB (publ) 30.67 Million SEK 100.0%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 100.0%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 100.0%
Modus Therapeutics Holding AB (publ) - SEK NaN%
Xspray Pharma AB (publ) 31.94 Million SEK 100.0%
Simris Alg AB (publ) 90.74 Million SEK 100.0%
Ziccum AB (publ) 286 Thousand SEK 100.0%
SynAct Pharma AB 58 Thousand SEK 100.0%
OncoZenge AB (publ) - SEK NaN%
Camurus AB (publ) 13.61 Million SEK 100.0%
2cureX AB (publ) - SEK NaN%
Asarina Pharma AB (publ) 1 Million SEK 100.0%
Isofol Medical AB (publ) - SEK NaN%
Stayble Therapeutics AB (publ) 850 Thousand SEK 100.0%
I-Tech AB - SEK NaN%
Cyxone AB (publ) 74 Thousand SEK 100.0%
Biosergen AB - SEK NaN%
Annexin Pharmaceuticals AB (publ) - SEK NaN%
Alzinova AB (publ) 800 Thousand SEK 100.0%
Oncopeptides AB (publ) 106.48 Million SEK 100.0%
Guard Therapeutics International AB (publ) - SEK NaN%
Pila Pharma AB (publ) - SEK NaN%
Ascelia Pharma AB (publ) 176 Thousand SEK 100.0%
Diagonal Bio AB (publ) - SEK NaN%